国际皮肤性病学杂志    2004 30 (1): 20-22   ISSN: 2096-5540  CN: 32-1880/R  

系统性红斑狼疮发病机制的研究进展
钟华, 郝飞
第三军医大学附属西南医院皮肤科 重庆 400038
收稿日期 2003-03-13  修回日期 null  网络版发布日期 null
参考文献  [1] Takahashi T,Tanaka M,Brannan CI,et al.Generalized lymphoproliferative disease in mice,caused by a point mutation in the Fas ligand.Cell,1994,76(6):969-976.
[2] Nagata S,Golstein P.The Fas death factor.Science,1995,267(5203):1449-1456.
[3] Cheng J,Zhou T,Liu C,et al.Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.Science,1994,263(5154):1759-1762.
[4] Wu J,Metz C,Xu X,et al.A novel polymorphic CAAT/enhancerBinding protein beta element in the FasL gene promoter alters Fas ligand expression:a candidate background gene in African American systemic lupus erythematosus patients.J Immunol,2003,170(1):132-138.
[5] Goerg S.The association between systemic lupus erythematosus and deficiencies of the complement system.Cell Mol Biol(Noisy-legrand),2002,48(3):237-245.
[6] Rafnar BO,Traustadottir KH,Sigfusson A,et al.An enzyme based assay for the measurement of complement mediated binding of immune complexes to red blood cells.J Immunol Methods,1998,211(1-2):171-181.
[7] Nielsen CH,leslie RG.Complement's participation in acquired immunity.J Leukoc Biol,2002,72(2):249-261.
[8] Tsao BP.An update on genetic studies of systemic lupus erythematosus.Curr Rhematal Rep,2002,4(4):359-367.
[9] Marzocchi-Machado CM,Alves CM,Azzolini AE,et al.Fcgamma and complement receptors:expression,role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients.Lupus,2002,11(4):240-248.
[10] Traynor AE,Bart WG,Rosa RM,et al.Hematopoietic stem cell transplantation for severe and refractory lupus.Analysis after five years and fifteen patients.Arthritis Rheum,2002,46(11):2917-1923.
[11] Blanco P,Palucka AK,Gill M,et al.Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.Science,2001,294(5546):1540-1543.
[12] Stewart JJ.Theory and treatment of the X-inactivation chimera in female-prevalent autoimmune disease.Arch Immunol Ther Exp(Warsz),1999,47(6):355-259.
[13] Matsuo M,Muroya K,Nanao K,et al.Mother and daughter with 45,X/46,X,r(X)(p22.3q28)and mental retardation:analysis of the X-inactivation patterns.Am J Med Genet,2000,91(4):267-272.

通讯作者: